8-K Announcements
6Material company update
Apr 8, 2026·SEC
Material company update
Mar 9, 2026·SEC
Material company update
Mar 6, 2026·SEC
Vicarious Surgical Inc.(RBOT)Earnings, Financials & Key Ratios
RBOT•NYSE
Price updated Jun 19, 2026
AboutVicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Show more
- Revenue$0
- EBITDA-$50M+23.1%
- Net Income-$50M+20.6%
- EPS (Diluted)-8.45+21.2%
- ROE-177.51%-103.1%
RBOT Key Insights
Vicarious Surgical Inc. (RBOT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.1x book value
✗Weaknesses
- ✗Profits declining 31.3% over 5 years
- ✗Weak Piotroski F-Score: 1/9
- ✗Weak momentum: RS Rating 1 (bottom 1%)
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when RBOT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
RBOT Price & Volume
Vicarious Surgical Inc. (RBOT) stock price & volume — 10-year historical chart
Loading chart...
RBOT Growth Metrics
Vicarious Surgical Inc. (RBOT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM31.65%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM35.41%
Return on Capital
10 Years-73.01%
5 Years-73.91%
3 Years-92.57%
Last Year-134.61%
RBOT Peer Comparison
Vicarious Surgical Inc. (RBOT) competitors in Surgical tools, endoscopy, and robotics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 | |
 MASI | 9.42B | 179.95 | -64.27 | -27.1% | 4.9% | 9.08% | 0.78 | |
 SSYS | 768.66M | 8.92 | -6.97 | -3.73% | -21.01% | -13.44% | 0.03 | |
 TMCI | 271.82M | 4.19 | -4.51 | 1.59% | -29.44% | -69.5% | 0.16 | |
 SYK | 117.88B | 307.80 | 36.64 | 11.16% | 12.92% | 15.04% | 0.66 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 GMED | 10.69B | 79.23 | 20.21 | 16.65% | 18.92% | 13.04% | 0.03 |
Compare RBOT vs Peers
Vicarious Surgical Inc. (RBOT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RBOT Income Statement
Vicarious Surgical Inc. (RBOT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue Growth % | - | - | - | - | - | - | - | - |
Cost of Goods Sold | 0 | 0 | 0 | 0 | 1.85M | 2.11M | 1.43M | 826K |
COGS % of Revenue | - | - | - | - | - | - | - | - |
Gross Profit | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | -1.85M▲ 0% | -2.11M▼ 13.6% | -1.43M▲ 32.4% | -826K▲ 0% |
Gross Margin % | - | - | - | - | - | - | - | - |
Gross Profit Growth % | - | - | - | - | - | -13.65% | 32.37% | - |
Operating Expenses | 9.78M | 12.98M | 38.22M | 80.08M | 78.81M | 64.45M | 49.54M | 41.9M |
OpEx % of Revenue | - | - | - | - | - | - | - | - |
Selling, General & Admin | 2.3M | 3.19M | 16.16M | 36.18M | 33.09M | 26.4M | 17.37M | 13.5M |
SG&A % of Revenue | - | - | - | - | - | - | - | - |
Research & Development | 7.48M | 9.8M | 22.06M | 43.9M | 47.58M | 40.16M | 33.6M | 29.23M |
R&D % of Revenue | - | - | - | - | - | - | - | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | -1.85M | -2.11M | -1.43M | -826K |
Operating Income | -9.78M▲ 0% | -12.98M▼ 32.7% | -38.22M▼ 194.4% | -80.08M▼ 109.5% | -80.67M▼ 0.7% | -66.56M▲ 17.5% | -50.97M▲ 23.4% | -42.72M▲ 0% |
Operating Margin % | - | - | - | - | - | - | - | - |
Operating Income Growth % | - | -32.73% | -194.36% | -109.5% | -0.73% | 17.49% | 23.42% | - |
EBITDA | -9.68M | -12.83M | -37.91M | -78.97M | -78.81M | -64.45M | -49.54M | -41.48M |
EBITDA Margin % | - | - | - | - | - | - | - | - |
EBITDA Growth % | - | -32.53% | -195.5% | -108.32% | 0.2% | 18.23% | 23.13% | 35.42% |
D&A (Non-Cash Add-back) | 104K | 157K | 316K | 1.11M | 1.85M | 2.11M | 1.43M | 1.24M |
EBIT | -9.78M | -12.98M | -35.12M | 5.36M | -71.05M | -63.22M | -50.97M | -42.28M |
Net Interest Income | 469 | 110K | -69K | 1.24M | 4.4M | 3.29M | 973K | 567K |
Interest Income | 469 | 113K | 20K | 1.44M | 4.43M | 3.29M | 973K | 567K |
Interest Expense | 0 | 3K | 89K | 200K | 25K | 0 | 0 | 0 |
Other Income/Expense | 469K | 110K | 3.02M | 85.23M | 9.6M | 3.33M | 786K | 606K |
Pretax Income | -9.31M▲ 0% | -12.88M▼ 38.2% | -35.21M▼ 173.5% | 5.16M▲ 114.6% | -71.07M▼ 1478.1% | -63.22M▲ 11.0% | -50.18M▲ 20.6% | -42.12M▲ 0% |
Pretax Margin % | - | - | - | - | - | - | - | - |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -9.31M▲ 0% | -12.88M▼ 38.2% | -35.21M▼ 173.5% | 5.16M▲ 114.6% | -71.07M▼ 1478.1% | -63.22M▲ 11.0% | -50.18M▲ 20.6% | -42.12M▲ 0% |
Net Margin % | - | - | - | - | - | - | - | - |
Net Income Growth % | - | -38.23% | -173.45% | 114.65% | -1478.15% | 11.04% | 20.63% | 31.65% |
Net Income (Continuing) | -9.31M | -12.88M | -35.21M | 5.16M | -71.07M | -63.22M | -50.18M | -42.12M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1.70▲ 0% | -3.76▼ 121.2% | -10.92▼ 190.4% | 1.21▲ 111.1% | -14.60▼ 1306.6% | -10.72▲ 26.6% | -8.45▲ 21.2% | -6.29▲ 0% |
EPS Growth % | - | -121.18% | -190.43% | 111.08% | -1306.61% | 26.58% | 21.18% | 35.41% |
EPS (Basic) | -1.70 | -3.76 | -10.92 | 1.27 | -14.70 | -10.72 | -8.45 | - |
Diluted Shares Outstanding | 5.47M | 3.42M | 3.22M | 4.25M | 4.87M | 5.89M | 5.94M | 6.7M |
Basic Shares Outstanding | 5.46M | 3.42M | 3.22M | 4.29M | 4.83M | 5.89M | 5.94M | 6.7M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
RBOT Balance Sheet
Vicarious Surgical Inc. (RBOT) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 15.73M | 17.13M | 178.37M | 120.4M | 100.95M | 51.7M | 11.58M | 5.15M |
Cash & Short-Term Investments | 15.48M | 16.87M | 173.51M | 116.21M | 98.18M | 49.1M | 9.79M | 3.68M |
Cash Only | 2.16M | 16.87M | 173.51M | 116.21M | 52.82M | 9.74M | 2.57M | 1.41M |
Short-Term Investments | 13.32M | 0 | 0 | 0 | 45.35M | 39.36M | 7.22M | 2.27M |
Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Sales Outstanding | - | - | - | - | - | - | - | - |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - |
Other Current Assets | 255K | 0 | 0 | 4.2M | 2.78M | 2.6M | 1.79M | 1.47M |
Total Non-Current Assets | 630K | 663K | 3.31M | 19.89M | 18.91M | 16.02M | 8M | 7.43M |
Property, Plant & Equipment | 482K | 445K | 2.25M | 18.86M | 17.86M | 15.04M | 7.03M | 6.73M |
Fixed Asset Turnover | - | - | - | - | - | - | - | 0.00x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 345.19M | 0 | 936K | 0 | 0 | 0 | 936K |
Other Non-Current Assets | 148K | -344.97M | 1.05M | 92K | 1.05M | 985K | 965K | 702K |
Total Assets | 16.36M▲ 0% | 17.79M▲ 8.7% | 181.68M▲ 921.4% | 140.29M▼ 22.8% | 119.86M▼ 14.6% | 67.72M▼ 43.5% | 19.58M▼ 71.1% | 12.59M▲ 0% |
Asset Turnover | - | - | - | - | - | - | - | 0.00x |
Asset Growth % | - | 8.7% | 921.36% | -22.78% | -14.56% | -43.5% | -71.08% | -268.02% |
Total Current Liabilities | 622K | 814K | 6.25M | 8.39M | 7.28M | 7.67M | 3.9M | 3.35M |
Accounts Payable | 203K | 373K | 1.5M | 1.73M | 1.26M | 1.17M | 894K | 1.03M |
Days Payables Outstanding | - | - | - | - | 247.66 | 201.99 | 228.99 | 393.28 |
Short-Term Debt | 47K | 47K | 647K | 16K | 0 | 0 | 1.95M | 1.16M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 372K | 291K | 0 | 0 | 4.06M | 3.97M | 1.06M | 1.16M |
Current Ratio | 25.30x | 21.04x | 28.56x | 14.35x | 13.87x | 6.74x | 2.97x | 1.54x |
Quick Ratio | 25.30x | 21.04x | 28.56x | 14.35x | 13.87x | 6.74x | 2.97x | 1.54x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 111K | 121K | 92.34M | 20.85M | 14.62M | 13.35M | 5.84M | 5.67M |
Long-Term Debt | 111K | 63K | 691K | 0 | 0 | 0 | 0 | 5.67M |
Capital Lease Obligations | 0 | 0 | 0 | 14.83M | 13.79M | 12.57M | 5.84M | 29.25M |
Deferred Tax Liabilities | 0 | -12.07M | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 58K | 91.65M | 6.02M | 830K | 787K | 0 | 0 |
Total Liabilities | 733K | 935K | 98.59M | 29.25M | 21.89M | 21.02M | 9.74M | 9.02M |
Total Debt | 158K | 110K | 1.34M | 15.69M | 14.83M | 13.79M | 7.79M | 6.82M |
Net Debt | -2M | -16.76M | -172.17M | -100.52M | -37.99M | 4.05M | 5.22M | 5.42M |
Debt / Equity | 0.01x | 0.01x | 0.02x | 0.14x | 0.15x | 0.30x | 0.79x | 1.91x |
Debt / EBITDA | - | - | - | - | - | - | - | -0.16x |
Net Debt / EBITDA | - | - | - | - | - | - | - | -0.13x |
Interest Coverage | - | -4328.33x | -394.58x | 26.79x | -2841.84x | - | - | - |
Total Equity | 15.63M▲ 0% | 16.85M▲ 7.8% | 83.09M▲ 393.0% | 111.05M▲ 33.6% | 97.97M▼ 11.8% | 46.7M▼ 52.3% | 9.84M▼ 78.9% | 3.57M▲ 0% |
Equity Growth % | - | 7.81% | 393.03% | 33.64% | -11.78% | -52.33% | -78.93% | -312.02% |
Book Value per Share | 2.86 | 4.92 | 25.80 | 26.15 | 20.13 | 7.93 | 1.66 | 0.53 |
Total Shareholders' Equity | 15.63M | 16.85M | 83.09M | 111.05M | 97.97M | 46.7M | 9.84M | 3.57M |
Common Stock | 1K | 9K | 12K | 13K | 17K | 17K | 17K | 17K |
Retained Earnings | -18.72M | -31.59M | -66.8M | -61.64M | -132.71M | -195.94M | -246.12M | -253.45M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | -329.22M | 0 | 0 | 10K | 50K | 4K | -2K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RBOT Cash Flow Statement
Vicarious Surgical Inc. (RBOT) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -8.71M | -12.04M | -33.3M | -61.21M | -62.3M | -49.96M | -45.08M | -39.55M |
Operating CF Margin % | - | - | - | - | - | - | - | - |
Operating CF Growth % | - | -38.19% | -176.61% | -83.83% | -1.79% | 19.82% | 9.77% | 62.72% |
Net Income | -9.31M | -12.88M | -35.21M | 5.16M | -71.07M | -63.22M | -50.18M | -42.12M |
Depreciation & Amortization | 104K | 157K | 316K | 1.11M | 1.85M | 2.11M | 1.43M | 1.24M |
Stock-Based Compensation | 337K | 448K | 3.69M | 12.26M | 13.27M | 11.9M | 8.13M | 2.17M |
Deferred Taxes | 0 | 188.07K | -3.08M | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 64K | -188.07K | 21K | -83.1M | -5.61M | -150K | 451K | 4.51M |
Working Capital Changes | 98K | 232K | 955K | 3.36M | -746K | -594K | -4.91M | -5.35M |
Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 0 | 170K | 1.13M | 135K | -473K | -96K | -272K | 8.34K |
Cash from Investing | -1.85M | 13.2M | -1.29M | -5.35M | -45.78M | 6.86M | 32.15M | 32.53M |
Capital Expenditures | -246K | -120K | -1.29M | -5.35M | -1.67M | -180K | -132K | -135.71K |
CapEx % of Revenue | - | - | - | - | - | - | - | - |
Acquisitions | 0 | 344.99M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | -1.6M | 13.32K | 0 | 0 | 0 | 0 | 0 | 133K |
Cash from Financing | 10M | 13.52M | 192.16M | 9.14M | 44.7M | 8K | 5.76M | 5.59M |
Debt Issued (Net) | -27K | -48K | 1.3M | -1.4M | -16K | 0 | 525K | 372.24K |
Equity Issued (Net) | 0 | 13.52M | 0 | 10M | 47.24M | 8K | 5.24M | 5.23M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 10.03M | 43K | 190.86M | 542K | -2.53M | 0 | 0 | -13.77K |
Net Change in Cash | -559K▲ 0% | 14.68M▲ 2726.3% | 157.58M▲ 973.3% | -57.42M▼ 136.4% | -63.39M▼ 10.4% | -43.09M▲ 32.0% | -7.17M▲ 83.4% | -1.45M▲ 0% |
Free Cash Flow | -8.96M▲ 0% | -12.16M▼ 35.7% | -34.59M▼ 184.5% | -66.56M▼ 92.5% | -63.98M▲ 3.9% | -50.14M▲ 21.6% | -45.21M▲ 9.8% | -39.68M▲ 0% |
FCF Margin % | - | - | - | - | - | - | - | - |
FCF Growth % | - | -35.74% | -184.48% | -92.45% | 3.89% | 21.63% | 9.83% | 16.35% |
FCF per Share | -1.64 | -3.55 | -10.74 | -15.67 | -13.14 | -8.52 | -7.61 | -5.92 |
FCF Conversion (FCF/Net Income) | 0.94x | 0.93x | 0.95x | -11.87x | 0.88x | 0.79x | 0.90x | 0.94x |
Interest Paid | 2K | 3K | 36K | 41K | 1K | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RBOT Key Ratios
Vicarious Surgical Inc. (RBOT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -79.27% | -70.45% | 5.31% | -68.01% | -87.4% | -177.51% | -333.19% |
Return on Invested Capital (ROIC) | -141.86% | - | - | -171.62% | -90.16% | -116.17% | -159.79% |
Debt / Equity | 0.01x | 0.02x | 0.14x | 0.15x | 0.30x | 0.79x | 1.91x |
Interest Coverage | -4328.33x | -394.58x | 26.79x | -2841.84x | - | - | - |
FCF Conversion | 0.93x | 0.95x | -11.87x | 0.88x | 0.79x | 0.90x | 0.94x |
Related:RBOT Dividend History·RBOT Revenue History·RBOT Price History·RBOT P/E History·RBOT Financial Ratios·RBOT Institutional Holders
RBOT SEC Filings & Documents
Vicarious Surgical Inc. (RBOT) SEC filings — annual & quarterly reports (10-K, 10-Q)
RBOT Frequently Asked Questions
Vicarious Surgical Inc. (RBOT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Vicarious Surgical Inc. (RBOT) grew revenue by 0.0% over the past year. Growth has been modest.
Vicarious Surgical Inc. (RBOT) reported a net loss of $42.1M for fiscal year 2025.
Dividend & Returns
Vicarious Surgical Inc. (RBOT) has a return on equity (ROE) of -177.5%. Negative ROE indicates the company is unprofitable.
Vicarious Surgical Inc. (RBOT) had negative free cash flow of $39.7M in fiscal year 2025, likely due to heavy capital investments.